Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment

Xiaohong Xia(National Center for Clinical Laboratories), Hongbiao Huang(Harbin Institute of Technology)
International Journal of Biological Sciences
January 1, 2020
10.7150/ijbs.44005
Cited by 18

Related Papers

Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide
|Journal of Experimental & Clinical Cancer Research|2019|102
Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer
|Journal of Experimental & Clinical Cancer Research|2019|101
Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy
|Theranostics|2020|74
USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells
|Journal of Experimental & Clinical Cancer Research|2021|58
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
|Cell Death and Disease|2021|44